Form 8-K - Current report:
SEC Accession No. 0001104659-25-061142
Filing Date
2025-06-20
Accepted
2025-06-20 16:01:35
Documents
12
Period of Report
2025-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518439d2_8k.htm   iXBRL 8-K 27832
  Complete submission text file 0001104659-25-061142.txt   193251

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20250618.xsd EX-101.SCH 3005
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20250618_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20250618_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2518439d2_8k_htm.xml XML 3695
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 251061228
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)